Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NZE/BLT stock hub

NZE/BLT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NZE/BLTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.5M

New Zealand Stock Exchange

Market data

Price

Recent price action with selectable time range.

NZE/BLTNZE/BLT

—

Loading chart…

In the news

Latest news · NZE/BLT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E21.9

P25 n/aP50 n/aP75 n/a

ROE8.4

P25 n/aP50 n/aP75 n/a

ROIC16.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NZE/BLT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

NZD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	New Zealand
Country code	NZ
Employees	38
Employees Change	-1%
Employees Change Percent	-2.56
Enterprise value	NZD 12.2M
Exchange	New Zealand Stock Exchange
Financial currency	NZD
First seen	2026-05-10
Industry	Biotechnology
Isin	NZBLTE0002S8
Last refreshed	2026-05-10
Market cap	NZD 20.5M
Price	NZD 0.02
Price currency	NZD
Rev Per Employee	377,710.53x
Sector	Healthcare
Sic	2834
Symbol	nze/BLT
Website	https://www.blis.co.nz

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.02%
EV Earnings	11.91x
EV/EBIT	15.52x
EV/EBITDA	10.19x
EV/FCF	27.58x
EV/Sales	0.85x
FCF yield	2.17%
P/B ratio	1.6x
P/E ratio	21.89x
P/S ratio	1.43x
PE Ratio3 Y	18.1x
PE Ratio5 Y	36.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.5%
EBITDA Margin	7.05%
FCF margin	3.09%
Gross margin	73.91%
Gross Profit	NZD 10.6M
Gross Profit Growth	4.93%
Gross Profit Growth Q	10.33%
Gross Profit Growth3 Y	4.42%
Gross Profit Growth5 Y	5.58%
Net Income	NZD 1M
Net Income Growth	-33.46%
Net Income Growth Q	82.97%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth3 Y	16.75%
Pretax Margin	7.57%
Profit Margin	7.16%
Profit Per Employee	NZD 27,053
Profitable Years	2
ROA	3.51
Roa5y	-2.8
ROCE	6.02
ROE	8.4
Roe5y	-3.76
ROIC	16.43
Roic5y	-12.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.26%
Cagr15y	-7.9%
Cagr1y	6.67%
Cagr20y	-7.1%
Cagr3y	-16%
Cagr5y	-24.45%
EPS Growth	-43.99
EPS Growth Q	50
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	13.5
FCF Growth	-73.46%
FCF Growth3 Y	-21.16%
FCF Growth5 Y	51.3%
OCF Growth	-69.34%
OCF Growth10 Y	-11.13%
OCF Growth3 Y	-18.89%
OCF Growth5 Y	39.65%
Revenue Growth	12.31x
Revenue Growth Q	28.17x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	7.46x
Revenue Growth5 Y	6.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NZD 1.02
Assets	NZD 14.8M
Cash	NZD 8.8M
Current Assets	NZD 12.3M
Current Liabilities	NZD 1.7M
Debt	NZD 526,000
Debt EBITDA	NZD 0.44
Debt Equity	NZD 0.04
Debt FCF	NZD 1.18
Equity	NZD 12.8M
Interest Coverage	21.32
Liabilities	NZD 2M
Long Term Assets	NZD 2.4M
Long Term Liabilities	NZD 348,000
Net Cash	NZD 8.2M
Net Cash By Market Cap	NZD 40.18
Net Cash Growth	-2.49%
Net Debt EBITDA	NZD -8.13
Net Debt Equity	NZD -0.64
Net Debt FCF	NZD -18.52
Tangible Book Value	NZD 11.7M
Tangible Book Value Per Share	NZD 0.01
WACC	7.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.48
Inventory Turnover	2.74
Net Working Capital	NZD 2.1M
Quick ratio	6.15
Working Capital	NZD 10.7M
Working Capital Turnover	NZD 1.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.44%
Dividend per share	NZD 0
Last Dividend	NZD 0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.94%
1Y total return	6.67%
200-day SMA	0.02
3Y total return	-40.74%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-75.38%
All Time High	0.41
All Time High Change	-96.1%
All Time High Date	2003-02-19
All Time Low	0.01
All Time Low Change	166.67%
All Time Low Date	2012-10-02
ATR	0
Beta	0.64
Beta1y	0.61
Beta2y	0.04
Ch YTD	-5.88
High	0.02
High52	0.02
High52 Date	2025-07-02
High52ch	-27.27%
Low	0.02
Low52	0.01
Low52 Date	2026-04-02
Low52ch	23.08%
Ma50ch	0.63%
Price vs 200-day SMA	-4.19%
RSI	51.39
RSI Monthly	46.1
RSI Weekly	48.12
Sharpe ratio	0.43x
Sortino ratio	0.84
Total Return	-19.44%
Tr YTD	-5.88
Tr15y	-70.91%
Tr1m	-5.88%
Tr1w	-5.88%
Tr3m	-5.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NZD 789,000
Operating Income Growth	61.35
Operating Income Growth Q	937.5
Operating Income Growth3 Y	34.82
Operating margin	5.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	618,972,331%
Net Borrowing	-187,000
Shares Insiders	11.12%
Shares Institutions	15.7%
Shares Out	1,279,301,599
Shares Qo Q	-1.2%
Shares Yo Y	19.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NZD 444,000
Average Volume	268,950.25x
Bv Per Share	0.01
CAPEX	NZD -119,000
Ch10y	-52.94
Ch15y	-70.91
Ch1m	-5.88
Ch1w	-5.88
Ch1y	6.67
Ch20y	-88.06
Ch3m	-5.88
Ch3y	-40.74
Ch5y	-75.38
Ch6m	6.67
Change	6.67%
Change From Open	6.67
Close	0.02
Days Gap	0
Depreciation Amortization	223,000
Dollar Volume	509.4
Earnings Date	2026-05-22
EBIT	NZD 789,000
EBITDA	NZD 1M
EPS	NZD 0
F Score	4
FCF	NZD 444,000
FCF EV Yield	3.63x
FCF Per Share	NZD 0
Financing CF	-160,000
Fiscal Year End	March
Founded	2,000
Graham Number	0.01281
Graham Upside	-19.94
Income Tax	NZD 58,000
Investing CF	-819,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-09-30
Lynch Fair Value	NZD 0.01
Lynch Upside	-23.5
Ma150	0.02
Ma150ch	-1.84%
Ma20	0.02
Ma20ch	0.63%
Net CF	-468,000
Next Earnings Date	2026-05-22
Open	0.02
P FCF Ratio	46.1
P OCF Ratio	36.36
Position In Range	100
Ppne	1,018,000
Price Date	2026-05-07
Price EBITDA	NZD 20.23
Ptbv Ratio	1.76
Relative Volume	0.12x
Revenue	14,353,000x
Tax By Revenue	0.4x
Tax Rate	5.34%
Tr20y	-77.08%
Tr6m	6.67%
Volume	31,838
Z Score	4.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NZE/BLT pay a dividend?

Capital-return profile for this ticker.

Performance

NZE/BLT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NZE/BLT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.7%

Share of float held by funds and institutions

Insider ownership

+11.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+19.4%

Negative means the company is buying back shares.

Technical

NZE/BLT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.4

Neutral momentum band

Price vs 200-day MA

-4.2%

50/200-day relationship not available

Beta (5Y)

0.64

Less volatile than the market

Sharpe ratio

0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NZE/BLT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nze/BLT stock rating?

nze/BLT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nze/BLT analysis?

The full report lives at /stocks/nze/BLT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nze/BLT?

The latest report frames nze/BLT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nze/BLT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.